Brian is a seasoned pharmaceutical and biotech leader with nearly three decades of experience spanning all phases of drug development, medical affairs, and commercialization. Currently working on HAE with Pharvaris Inc.  Prior to that, spent many years in the rare disease space,as Vice President, Global Medical Head of the Epilepsy Franchise at Praxis Precision Medicines, where he was responsible for global medical strategy, clinical execution, and scientific communications to advance innovation in epilepsy and strengthen the company’s position as a leader among healthcare providers and key opinion leaders.

Throughout his career, Brian has held senior leadership roles across neurology, psychiatry, rare disease, and gene therapy. At Pear Therapeutics, he guided medical affairs strategy for addiction and digital therapeutics, while at PTC Therapeutics he served as Medical Head for Huntington’s disease and rare genetic programs, designing Phase 1–3 trials, shaping regulatory submissions, and supporting gene therapy launches. Earlier, at SK Life Science, he built the medical affairs function for epilepsy and prepared the strategy for the cenobamate launch. He also held leadership and field medical roles at Ironwood, Lundbeck, and Novartis, contributing to product launches, advisory boards, and medical-scientific communication platforms that enhanced patient access and clinical adoption.

A strategic and entrepreneurial leader, Brian is recognized for building and scaling medical affairs organizations, developing cross-functional launch strategies, and forging strong networks with investigators, patient advocacy groups, and payers. His expertise extends to rare diseases, decentralized trials, market access strategy, and real-world evidence generation, as well as regulatory and compliance frameworks (FDA, GCP, GMP, NDA).

Brian holds a PhD in Psychology (Cognition), an MBA, and a BA in Psychology and German with a focus in neuropharmacology. He brings a global perspective to his work. His professional commitment is deeply personal—shaped by his experience as a parent of a child with epilepsy—driving his dedication to advancing therapies that improve the lives of patients and families affected by rare neurological disorders.

“As a parent, I could not be more excited about working to improve the lives of families like mine.  In order to achieve this, I left my old role so I can spend time finding answers for community. This opportunity affords me the chance to make a difference. “